Accurkardia Inc
AccurKardia Inc, based in New York, NY, specializes in leveraging artificial intelligence to interpret both visible and hidden signals within electrocardiograms (ECGs), transforming them into powerful diagnostic tools and broad biomarkers that enhance patient outcomes and save lives. Their flagship application, AccurECG, has received FDA clearance and streamlines ECG interpretation, while novel applications extend the use of ECGs beyond traditional capabilities for the detection and management of various health conditions.
The company also offers AKAVS and AKGuard, which are currently under development and intended solely for investigational purposes, not yet cleared or approved by the FDA for clinical use. All information provided by AccurKardia is for informational purposes only and should not be considered medical, legal, or professional advice, emphasizing the importance of consulting qualified healthcare providers for clinical decision-making.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.

